Related references
Note: Only part of the references are listed.Persisting Remodeling and Less Airway Wall Eosinophil Activation in Complete Remission of Asthma
Martine Broekema et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Efficacy and Safety of Subcutaneous Omalizumab vs Placebo as Add-on Therapy to Corticosteroids for Children and Adults With Asthma A Systematic Review
Gustavo J. Rodrigo et al.
CHEST (2011)
Noneosinophilic asthma in children: relation with airway remodelling
S. Baraldo et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
An Official Research Policy Statement of the American Thoracic Society/European Respiratory Society: Standards for Quantitative Assessment of Lung Structure
Connie C. W. Hsia et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Therapeutic targets for persistent airway inflammation in refractory asthma
Patrick Murphy et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma
Jean Bousquet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Asthma: Clinical expression and molecular mechanisms
Robert F. Lemanske et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Italian real-life experience of omalizumab
M. Cazzola et al.
RESPIRATORY MEDICINE (2010)
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Pranabashis Haldar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update
Stephen Holgate et al.
RESPIRATORY MEDICINE (2009)
Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts
D. Descalzi et al.
ALLERGY (2008)
Clinical relevance of airway remodelling in airway diseases
A. L. James et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Specificity of basement membrane thickening in severe asthma
Arnaud Bourdin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Quantitative morphology using bronchial biopsies
P. G. Woodruff et al.
EUROPEAN RESPIRATORY REVIEW (2006)
Asthma: defining of the persistent adult phenotypes
Sally E. Wenzel
LANCET (2006)
Structural changes in airway diseases - Characteristics, mechanisms, consequences, and pharmacologic modulation
C Bergeron et al.
CHEST (2006)
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment):: INNOVATE
M Humbert et al.
ALLERGY (2005)
The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma
J Bousquet et al.
ALLERGY (2005)
Refractory eosinophilic airway inflammation in severe asthma - Effect of parenteral corticosteroids
A ten Brinke et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma
R Djukanovic et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Omalizumab-induced reductions in mast cell FcεRI expression and function
LA Beck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammation
C Miranda et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone
A Chetta et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders
ES Schulman
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Share Paper
